Draganfly Announces Agreement to Pilot Drone Delivery Services Program for Mass General Brigham’s Home Hospital
Draganfly Inc. (NASDAQ: DPRO) partners with Mass General Brigham to provide medical drone deliveries for Home Hospital patients. The agreement aims to enhance patient care, improve access to essential services, and create more cost-effective solutions. The drone technology will reduce traffic-related delays, eliminate challenges with traditional transportation, and enable swift delivery of critical medicines, technical equipment, and laboratory work. This partnership is a significant step forward in the healthcare industry, creating a better and healthier future for patients in need.
The partnership between Draganfly and Mass General Brigham represents a significant advancement in the application of drone technology within the healthcare sector. The use of drones for just-in-time delivery of medical supplies can offer substantial benefits in terms of reducing delivery times and improving patient care , particularly in a dense urban area like Boston where traffic can impede timely delivery.
From a strategic standpoint, this move could position Draganfly as a pioneer in a niche market, potentially leading to increased demand for their services from other healthcare providers. For Mass General Brigham, the integration of drones may lead to operational efficiencies and cost savings, as well as enhanced patient satisfaction due to faster delivery of critical care items. The long-term implications could include a reduction in hospital readmissions and a shift towards home-based care models , which have been gaining traction as a means to reduce healthcare costs and improve patient quality of life.
The deployment of drones for medical deliveries is a complex endeavor that requires careful consideration of regulatory compliance, patient safety and data security. Drones must operate under stringent Federal Aviation Administration (FAA) regulations that govern airspace usage and safety. Moreover, the transportation of sensitive items such as medicines and lab work necessitates robust protocols to maintain chain-of-custody and ensure temperature control during transit.
Draganfly's technology will need to demonstrate reliability and accuracy in mapping delivery routes, which is critical in avoiding errors that could lead to misplaced deliveries or compromised patient care . As this technology becomes more widespread, it could lead to innovations in logistics within the healthcare industry, potentially setting new standards for the delivery of home healthcare services.
The announcement of Draganfly's agreement with Mass General Brigham is likely to be viewed positively by investors, as it indicates a diversification of revenue streams and entrance into a growing sector . The healthcare industry's increasing focus on home-based care and technology adoption suggests a growing market for Draganfly's services. However, investors should consider the scalability of such services and the company's capacity to manage growth while maintaining service quality.
Financially, the key metrics to watch would include the cost of service delivery , the pricing model for healthcare clients and the impact on profit margins . If successful, this could lead to improved financial performance for Draganfly and potentially provide a competitive edge. However, the capital expenditure associated with technology development and infrastructure to support drone deliveries will be critical factors in evaluating the long-term financial viability of this venture.
01/16/2024 - 07:15 AM
Just-in-time medical drone deliveries by Draganfly to include critical medicines, technical equipment, and laboratory work to benefit patient care.
Boston, MA., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce an agreement with Mass General Brigham to provide drone delivery and solutions for the healthcare system’s Home Hospital patients. Home Hospital aims to create a model that enhances the overall patient experience, improves access to essential services, and provides more cost-effective solutions for its patients.
Mass General Brigham’s Home Hospital is one of the largest in the country. Draganfly’s drone technology and pilot services will map and develop delivery routes to support the needs of both patients and staff.
Draganfly's technology aims to enhance the quality of care and support for Mass General Brigham’s Home Hospital patients by reducing traffic-related delays around its geographic catchment of the greater Boston metro area, eliminating challenges associated with traditional transportation methods, and enabling the swift and efficient delivery of essential supplies. The medical drone pick-up and deliveries facilitated by Draganfly's technology can include critical medicines, technical equipment, and laboratory work.
"At Mass General Brigham, we are looking at the future of healthcare, and part of that vision is taking care of patients in the comfort of their homes,” said David Levine, MD, MPH, MA, clinical director of research and development, Mass General Brigham Healthcare at Home. “In accomplishing this at scale, we understand that we need to continue to evolve our processes to support home-based care. These types of technological solutions allow us the opportunity to create a paradigm shift in our care delivery.”
“This is an exciting step forward in the healthcare industry that will help to create a better and healthier future for those who need it,” said Cameron Chell, President and CEO of Draganfly. “Our drone technology will minimize potential delays in ground transportation, providing a distinct advantage to medication delivery. The speed and convenience these drones can operate underscores their need in the healthcare industry.”
About Draganfly
Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) is the creator of quality, cutting-edge drone solutions, software, and AI systems that revolutionize how organizations do business and service their stakeholders. Recognized as being at the forefront of technology for over 24 years, Draganfly is an award-winning industry leader serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.
For more information on Draganfly, please visit us at www.draganfly.com https://www.thecse.com/en/listings/technology/draganfly-inc , https://www.nasdaq.com/market-activity/stocks/dpro https://www.boerse-frankfurt.de/equity/draganfly-inc-1 .
Media Contact media@draganfly.com
Company Contact info@draganfly.com
Forward-Looking Statements
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements include, but are not limited to, statements with respect to Draganfly technology’s ability to eliminate challenges associated with traditional transportation methods and enable the swift and efficient delivery of essential supplies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the COVID-19 pandemic, on the Company’s business, operations and financial condition; the successful integration of technology; the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates; the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions; and liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in Canada on the SEDAR website at www.sedar.com www.sec.gov
#
What is the partnership between Draganfly and Mass General Brigham about?
The partnership aims to provide medical drone deliveries for Home Hospital patients to enhance patient care, improve access to essential services, and create more cost-effective solutions.
What are the benefits of Draganfly's drone technology for Mass General Brigham's Home Hospital patients?
The drone technology will reduce traffic-related delays, eliminate challenges with traditional transportation, and enable swift delivery of critical medicines, technical equipment, and laboratory work.
Who is the clinical director of research and development at Mass General Brigham Healthcare at Home?
David Levine, MD, MPH, MA, is the clinical director of research and development at Mass General Brigham Healthcare at Home.
What is the role of Cameron Chell in Draganfly?
Cameron Chell is the President and CEO of Draganfly.
